Exiqon and MultiD Sign Development and Distribution Agreement to provide specifically adapted microRNA qPCR analysis solution

COPENHAGEN, DK, AND GOTHENBURG, SE, 25 May 2010 - Exiqon A/S, a leader in
microRNA analysis products and services, and MultiD Analyses  AB, a leader in
comprehensive software solutions for qPCR data analysis, today announced a
Development and Distribution  Agreement  incorporating a specifically adapted
version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR
platform. The agreement allows Exiqon to sell a fully compatible and
comprehensive data analysis solution to complete their microRNA qPCR offering. 

“The partnership between MultiD  and Exiqon has lead to the development of a
customized version of the  advanced GenEx data analysis program which has been
specifically adapted to allow easy  pre-processing and analysis of data from
the Exiqon microRNA PCR panels and assays,” said Henrik M. Pfundheller, VP
Sales & Marketing of Exiqon. “Exiqon offers the best performing qPCR reagents
for microRNA expression profiling on the market. However, we feel it is just as
important that our customers process, normalize and analyze their qPCR data
properly and with confidence. The addition of the Exiqon GenEx software to our
microRNA qPCR portfolio enables customers to get the most out of their microRNA
expression profiling experiments in an easy and convenient way”. 

“We have developed a special Plate Design module which enables Exiqon's
customers to design their qPCR experiment in silico and generate templates for
import into their real-time PCR instrument,” said Mikael Kubista,  Chairman of
MultiD. “These templates also allow fast and easy import of the results into
GenEx for pre-processing and analysis. The Exiqon GenEx software really
streamlines the experimental process from planning through generation of
results to data analysis.” 

MultiD's GenEx software is well established software for processing and
analysis of qPCR data. It includes everything from selection and validation of
reference genes, data pre-processing and advanced statistical methods to
analyze real-time qPCR data with simple clicks of the mouse. Possibly the most
important part of qPCR experiments is the pre-processing of raw data for
subsequent statistical analysis. Pre-processing steps need to be performed with
consistence, in the correct order and with confidence. GenEx has a streamlined
and user-friendly interface which aids data handling.  Powerful presentation
tools generate professional illustrations of even the most complex experimental
designs. 

Exiqon's miRCURY LNA™ Universal RT microRNA PCR system offers the best
available combination of performance and ease-of-use on the microRNA real-time
PCR market. The use of two LNA™-enhanced PCR primers results in both
exceptional sensitivity and specificity, enabling both accurate quantification
of very low microRNA levels and discrimination between closely related microRNA
sequences. The universal RT step greatly reduces sample input requirements and
technical variation, and most importantly saves time in the laboratory. The
product line includes microRNA Ready-to-Use PCR panels for exceptionally
sensitive expression profiling of 730 human microRNAs, individual microRNA
assays, reference gens and reagent kits. 

Additional information:
Henrik M. Pfundheller, VP Sales & Marketing, Exiqon A/S 
+45 4565 0420 
hmp@exiqon.com 

Johan Hult, Business Developer, MultiD Analyses AB
+46 733-145252
Johan.hult@multid.se

See the full press release in the attached PDF or at
www.exiqon.com/investor/portal